Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328–337 (2013).

CAS  Article  Google Scholar 

Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81–94 (2018).

CAS  Article  Google Scholar 

Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017).

CAS  Article  Google Scholar 

Shackleton, M., Quintana, E., Fearon, E. R. & Morrison, S. J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822–829 (2009).

CAS  Article  Google Scholar 

Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283–296 (2012).

CAS  Article  Google Scholar 

Shibue, T. & Weinberg, R. A. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol. 14, 611–629 (2017).

Article  Google Scholar 

Baumann, M., Krause, M. & Hill, R. Exploring the role of cancer stem cells in radioresistance. Nat. Rev. Cancer 8, 545–554 (2008).

CAS  Article  Google Scholar 

Shlush, L. I. et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature 547, 104–148 (2017).

CAS  Article  Google Scholar 

Ye, X. et al. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525, 256–260 (2015).

CAS  Article  Google Scholar 

Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. & Rich, J. N. Cancer stem cells in glioblastoma. Genes Dev. 29, 1203–1217 (2015).

CAS  Article  Google Scholar 

Zeuner, A., Todaro, M., Stassi, G. & De Maria, R. Colorectal cancer stem cells: from the crypt to the clinic. Cell Stem Cell 15, 692–705 (2014).

CAS  Article  Google Scholar 

Pece, S. et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62–73 (2010).

CAS  Article  Google Scholar 

Eramo, A. et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504–514 (2008).

CAS  Article  Google Scholar 

Hurt, E. M., Kawasaki, B. T., Klarmann, G. J., Thomas, S. B. & Farrar, W. L. CD44⁺CD24⁻ prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br. J. Cancer 98, 756–765 (2008).

CAS  Article  Google Scholar 

Saygin, C., Matei, D., Majeti, R., Reizes, O. & Lathia, J. D. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell 24, 25–40 (2019).

CAS  Article  Google Scholar 

de Thé, H Differentiation therapy revisited. Nat. Rev. Cancer 18, 117–127 (2018).

Article  CAS  Google Scholar 

Hu, J. et al. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc. Natl Acad. Sci. USA 106, 3342–3347 (2009).

CAS  Article  Google Scholar 

Piccirillo, S. G. et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761–765 (2006).

CAS  Article  Google Scholar 

Yoldi, G. et al. RANK signaling blockade reduces breast cancer recurrence by inducing tumor cell differentiation. Cancer Res. 76, 5857–5869 (2016).

CAS  Article  Google Scholar 

Shimokawa, M. et al. Visualization and targeting of LGR5⁺ human colon cancer stem cells. Nature 545, 187–192 (2017).

CAS  Article  Google Scholar 

Ginestier, C. et al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 8, 3297–3302 (2009).

CAS  Article  Google Scholar 

Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633–644 (2011).

CAS  Article  Google Scholar 

Samanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L. & Semenza, G. L. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc. Natl Acad. Sci. USA 111, E5429–E5438 (2014).

CAS  Article  Google Scholar 

Wang, C. et al. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol. Rep. 28, 1301–1308 (2012).

CAS  Article  Google Scholar 

Zheng, X., Cui, D., Xu, S., Brabant, G. & Derwahl, M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int. J. Oncol. 37, 307–315 (2010).

CAS  Article  Google Scholar 

Li, Y., Atkinson, K. & Zhang, T. Combination of chemotherapy and cancer stem cell targeting agents: preclinical and clinical studies. Cancer Lett. 396, 103–109 (2017).

CAS  Article  Google Scholar 

Dicko, A., Mayer, L. D. & Tardi, P. G. Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo. Expert Opin. Drug Deliv. 7, 1329–1341 (2010).

CAS  Article  Google Scholar 

Sun, R. et al. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells. Biomaterials 37, 405–414 (2015).

CAS  Article  Google Scholar 

Mu, L. M. et al. Development of functional dendrisomes based on a single molecule of polyesterbenzylether dendrimer and their application in cancer stem cell therapy. NPG Asia Mater. 11, 1–16 (2019).

Article  Google Scholar 

Sengupta, S. et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436, 568–572 (2005).

CAS  Article  Google Scholar 

Kolishetti, N. et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc. Natl Acad. Sci. USA 107, 17939–17944 (2010).

CAS  Article  Google Scholar 

Pouyssegur, J., Dayan, F. & Mazure, N. M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437–443 (2006).

CAS  Article  Google Scholar 

Borovski, T., Felipe De Sousa, E. M., Vermeulen, L. & Medema, J. P. Cancer stem cell niche: the place to be. Cancer Res. 71, 634–639 (2011).

CAS  Article  Google Scholar 

Mohyeldin, A., Garzon-Muvdi, T. & Quinones-Hinojosa, A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7, 150–161 (2010).

CAS  Article  Google Scholar 

Yu, J. et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc. Natl Acad. Sci. USA 112, 8260–8265 (2015).

CAS  Article  Google Scholar 

Gudas, L. J. & Wagner, J. A. Retinoids regulate stem cell differentiation. J. Cell. Physiol. 226, 322–330 (2011).

CAS  Article  Google Scholar 

Saravanakumar, G., Kim, J. & Kim, W. J. Reactive-oxygen-species-responsive drug delivery systems: Promises and challenges. Adv. Sci. 4, 1600124 (2017).

Article  CAS  Google Scholar 

Shi, X., Zhang, Y., Zheng, J. & Pan, J. Reactive oxygen species in cancer stem cells. Antioxid. Redox Signal. 16, 1215–1228 (2012).

CAS  Article  Google Scholar 

Diehn, M. et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780–783 (2009).

CAS  Article  Google Scholar 

Saretzki, G. et al. Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells 26, 455–464 (2008).

CAS  Article  Google Scholar 

Ye, X. Q. et al. Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int. J. Cancer 129, 820–831 (2011).

CAS  Article  Google Scholar 

Kobayashi, C. I. & Suda, T. Regulation of reactive oxygen species in stem cells and cancer stem cells. J. Cell. Physiol. 227, 421–430 (2012).

CAS  Article  Google Scholar 

Liou, G.-Y. & Storz, P. Reactive oxygen species in cancer. Free Radic. Res. 44, 479–496 (2010).

CAS  Article  Google Scholar 

Wang, Q., Yang, W., Uytingco, M. S., Christakos, S. & Wieder, R. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res. 60, 2040–2048 (2000).

CAS  Google Scholar 

Bertozzi, D. et al. The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1α activity by changing miR expression patterns in human cancer cells. Mol. Cancer Ther. 13, 239–248 (2014).

CAS  Article  Google Scholar 

Baranello, L., Bertozzi, D., Fogli, M. V., Pommier, Y. & Capranico, G. DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1α gene locus. Nucleic Acids Res. 38, 159–171 (2009).

Article  CAS  Google Scholar 

Hirschmann-Jax, C. et al. A distinct ‘side population’ of cells with high drug efflux capacity in human tumor cells. Proc. Natl Acad. Sci. USA 101, 14228–14233 (2004).

CAS  Article  Google Scholar 

Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555–567 (2007).

CAS  Article  Google Scholar 

Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).

CAS  Article  Google Scholar 

Sato, A. et al. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Res. 12, 119–131 (2014).

CAS  Article  Google Scholar 

Owusu-Ansah, E. & Banerjee, U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 461, 537–541 (2009).

CAS  Article  Google Scholar 

Topaly, J., Zeller, W. J. & Fruehauf, S. Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells. Leukemia 15, 342–347 (2001).

CAS  Article  Google Scholar 

Thambi, T. et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials 35, 1735–1743 (2014).

CAS  Article  Google Scholar 

Sarkadi, B., Homolya, L., Szakacs, G. & Varadi, A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev. 86, 1179–1236 (2006).

CAS  Article  Google Scholar 

Peach, R. J., Hollenbaugh, D., Stamenkovic, I. & Aruffo, A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122, 257–264 (1993).

CAS  Article  Google Scholar